Search research articles
Contact Us
Filters
Showing results (1-10 of 89) with videos related to
Page
of 9
Sort By:
The Journal of Allergy and Clinical Immunology
|
March 19, 2022
Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD<sub>2</sub> receptor?
Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
June 18, 2021
Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease
Katherine N Cahill
JAMA Internal Medicine
|
November 18, 2024
Borrowing From the Type 2 Diabetes Armamentarium for Asthma
Katherine N Cahill, Dinah Foer
Diabetes Care
|
July 21, 2021
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352
Dinah Foer, Katherine N Cahill
Immunology and Allergy Clinics of North America
|
April 26, 2022
Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity
Kristen B Corey, Katherine N Cahill
The Journal of Allergy and Clinical Immunology. in Practice
|
May 10, 2017
Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs
Tanya M Laidlaw, Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
March 26, 2023
Mechanistic and clinical updates in AERD: 2021-2022
Whitney W Stevens, Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
October 25, 2016
Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease
Katherine N Cahill, Joshua A Boyce
Immunology and Allergy Clinics of North America
|
October 8, 2016
Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease
Katherine N Cahill, Tanya M Laidlaw
The Journal of Allergy and Clinical Immunology
|
October 19, 2023
Reply
Whitney W Stevens, Katherine N Cahill
Page
of 9
Search research articles
Search
Showing results (1-10 of 89) with videos related to
Sort By:
Page
of 9
The Journal of Allergy and Clinical Immunology
|
March 19, 2022
Fevipiprant in CRSwNP and comorbid asthma: Wrong target population or wrong PGD<sub>2</sub> receptor?
Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
June 18, 2021
Immunologic effects of aspirin desensitization and high-dose aspirin therapy in aspirin-exacerbated respiratory disease
Katherine N Cahill
JAMA Internal Medicine
|
November 18, 2024
Borrowing From the Type 2 Diabetes Armamentarium for Asthma
Katherine N Cahill, Dinah Foer
Diabetes Care
|
July 21, 2021
Comment on Albogami et al. Glucagon-Like Peptide 1 Receptor Agonists and Chronic Lower Respiratory Disease Exacerbations Among Patients With Type 2 Diabetes. Diabetes Care 2021;44:1344-1352
Dinah Foer, Katherine N Cahill
Immunology and Allergy Clinics of North America
|
April 26, 2022
Aspirin-Exacerbated Respiratory Disease: A Unique Case of Drug Hypersensitivity
Kristen B Corey, Katherine N Cahill
The Journal of Allergy and Clinical Immunology. in Practice
|
May 10, 2017
Current Knowledge and Management of Hypersensitivity to Aspirin and NSAIDs
Tanya M Laidlaw, Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
March 26, 2023
Mechanistic and clinical updates in AERD: 2021-2022
Whitney W Stevens, Katherine N Cahill
The Journal of Allergy and Clinical Immunology
|
October 25, 2016
Aspirin-exacerbated respiratory disease: Mediators and mechanisms of a clinical disease
Katherine N Cahill, Joshua A Boyce
Immunology and Allergy Clinics of North America
|
October 8, 2016
Pathogenesis of Aspirin-Induced Reactions in Aspirin-Exacerbated Respiratory Disease
Katherine N Cahill, Tanya M Laidlaw
The Journal of Allergy and Clinical Immunology
|
October 19, 2023
Reply
Whitney W Stevens, Katherine N Cahill
Page
of 9